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An accurate measurement of total body fluid status is
extremely important in patients having hemodialysis (HD).
The “dry weight” is the post-dialysis weight after excess
body fluid has been removed by HD [1]. Patients who have
hypervolemic status develop hypertension, edema,
pulmonary congestion, and cardiovascular instability. In
contrast, patients who have hypovolemic status often have
general malaise, washed-out feeling, cramps, dizziness,
and shock after HD. Also, the dry weight often periodically
changes secondarily to a change of nutritional status and/
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The objective of the present study was to investigate whether InBody 2.0 might be useful in measuring the
dry weight of chronic hemodialysis (HD) patients. Thirty-five HD patients (22 males and 13 females; mean
age 62.6 ± 14.0 years; mean HD duration 101.0 ± 118.06 months) were examined. Multifrequency bioelectric
impedance analysis was used to estimate the ratio of extracellular water (ECW) to total body water (TBW).
The body resistance was measured at frequencies ranging from 1 kHz to 1 MHz. The impedance index was
determined at a low frequency (5 kHz) and correlated closely with ECW, using sodium bromide dilution as
standard comparison. The levels of serum albumin, prealbumin, total cholesterol (TC), triglycerides (TG),
transferrin, and human atrial natriuretic peptide (hANP) were measured by routine methods in our
hospital. The ECW/TBW ratio was significantly associated with the levels of hANP (p < 0.05). However, no
associations between the levels of serum albumin, TC, TG, or transferrin and the ECW/TBW were observed.
It appears that the body composition analyzer, InBody 2.0, may be useful for estimating the dry weight in
chronic HD patients.
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or additional catabolic disease. Therefore, the dry weight
of HD patients should frequently be evaluated.
Traditionally, the dry weight has been evaluated by high-
quality clinical assessments based on diagnostic skills and
experience. To address these problems, several methods
for estimating the dry weight are used, such as plasma
cyclic 3v,5v-guanosine monophosphate (cGMP), infrared
light reflection method, inferior vena cava diameter, chest
radiography, and clinical parameters including blood
pressure, intradialytic symptoms of volume depletion and
edema. The plasma levels of human atrial natriuretic
peptide (hANP) may be useful as a basis for adjusting the
dry weight, in addition to clinical judgment and chest
radiography [2–4].
Bioelectric impedance analysis (BIA) is a newly
developed, noninvasive, easy, and reproducible technique
to estimate the body fluid volume status [5]. In the present
study, the usefulness of BIA was compared with plasma
hANP levels for prediction of the dry weight in HD patients.
© 2006 Elsevier. All rights reserved.
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MATERIALS AND METHODS
Thirty-five stable HD patients participated in this study
after giving informed consent. The study was performed
30–60 minutes after the first dialysis session of the week
(Monday or Tuesday) at the outpatient HD center at Juntendo
University Hospital, Tokyo, Japan. Venous blood samples
were drawn at the beginning and end of each HD session.
Serum albumin, prealbumin, total cholesterol (TC),
triglycerides (TG), and transferrin were measured by routine
methods of the hospital central laboratory. Plasma hANP
levels were measured by the Eiken RIA Kit (Eiken Chemical
Co. Ltd, Tokyo, Japan). Body composition measurements
of postdialysis patients were carried out by segmental
bioelectric impedance, using eight tractile electrodes
according to the manufacturer’s instructions (InBody 2.0,
Biospace Co. Ltd, Seoul, Korea). A pair of electrodes was
placed on the surface of the thumb, palm, and fingers of the
hand, and ball of the foot and heel. With these electrodes,
microprocessor-controlled switches and impedance
analyzer were operated and segmental resistance was
measured at four frequencies (5, 50, 250, and 500 kHz).
Thus, a set of 20 segmental resistances was measured for
each individual. With these data, extracellular water (ECW),
total body water (TBW) and the ECW/TBW were calculated
from the sum of each segment, using the equations in the
BIA software [6,7].
According to the normal range of the ECW/TBW
provided by the manufacturer, patients were divided into
two groups: the edema group (n = 16), with ECW/TBW
more than or equal to 0.35; and the nonedema group
(n = 19), with ECW/TBW less than 0.34.
Statistical analysis
Data are expressed as mean ±  SD and compared with
unpaired Student’s t-test. The level of significance used in
all statistical analyses was 0.05.
RESULTS
The profiles of patients with or without edema are shown in
Table 1. There were no significant differences in gender,
age, and HD duration between the two groups. There were
no significant differences in the serum levels of prealbumin,
TC, TG, and transferrin between the edema and nonedema
groups (Table 2). There are no correlations between ECW/
TBW and hANP. Levels of plasma hANP in the edema and
nonedema groups are shown in Figure 1. The levels of
hANP in the edema group (ECW/TBW * 0.35) were
significantly higher than those in the nonedema group
(ECW/TBW < 0.34) (p < 0.05). However, there was no
significant difference in the levels of serum albumin between
these two groups (Figure 2).
Table 2. Relationship of extracellular water/total body water ratio (edema level) and laboratory data in post-hemodialysis patients
Prealbumin (mg/dL) Total cholesterol (mg/dL) Triglyceride (mg/dL) Transferrin (mg/dL)
Edema group 38.99 ± 4.75 202.94 ± 39.67 127.88 ± 80.39 224.19 ± 37.86
Nonedema group 36.44 ± 6.98 197.13 ± 43.45 130.13 ± 83.17 249.44 ± 68.84
Statistical significance ns ns ns ns
ns = not significant.
Table 1. Patient profile
Edema group Nonedema group Statistical significance
Patient number 16 19 ns
Gender (M/F) 9/7 13/6 ns
Age (yr) 71.0 ± 8.7 58.9 ± 15.5 ns
HD duration (months) 112.8 ± 159.8 81.2 ± 65.8 ns
HD = hemodialysis; ns = not significant.
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Ideally, the fluid status returns to normal extracellular
volume after HD treatment. In clinical practice, the dry
weight is defined as the post-dialysis weight at which all
or most excess body fluid has been removed. There are
several methods of estimating dry weight, including
inferior vena cava diameter, chest radiography, and clinical
parameters (e.g. blood pressure and intradialytic symptoms
of volume depletion and edema). However, these methods
lack reliable endpoints. Interobserver errors and the cost
of echocardiography obviate more widespread application
of measurement of inferior vena cava diameter [3]. Some
markers also proposed for assessment of dry weight in HD
patients are hANP and its second messenger cGMP, and
the infrared light reflection method [8], but the infrared
light reflection method cannot be evaluated in several
patients simultaneously. The clinical parameters depend
on the time at which ultrafiltration is performed in the
dialysis strategy, the predialysis body fluid status, and
concomitant drug treatment, such as antihypertensive
drugs [5].
BIA is a newly developed, noninvasive, easy, and
reproducible method for estimating the TBW in normal
adults. However, it is still controversial whether this method
can be used to estimate the dry weight of HD patients. de
Fijiter et al [9] and Kong et al [10] reported that BIA was
inaccurate in the assessment of TBW in HD patients. Their
studies were based on single-frequency BIA, however,
whereas multifrequency (MF) BIA was used in this study
[5]. Tsai et al reported that there were significant differences
of ECW/TBW and the ratio of intracellular fluid to
extracellular fluid between the edematous group and
nonedematous group [11]. They also pointed out that BIA
measurement of TBW may overestimate the actual volume
of ultrafiltration as a result of drinking or eating during HD,
or the body impedance during HD could be a consequence
of loss of conductive molecules.
In the present study, we showed that the ECW/TBW
was significantly associated with the levels of hANP in HD
patients. We have provided strong evidence that the fall in
plasma hANP levels in HD patients is mainly due to the
reduction in circulating plasma volume [4]. Zoccali et al
reported that plasma levels of hANP may be useful in
addition to clinical judgment and chest radiography as a
basis for adjusting dry weight [5]. Wann et al reported that
cGMP, the second messenger of hANP, could help predict
dry weight and avoid hypotension in HD patients [8].
However, the cost and complexity of the assays of hANP
limit their possible application. These findings suggest that
measurement of BIA is also useful for prediction of dry
weight in HD patients. This speculation is compatible with
other reports that MF BIA is a new method for prediction of
dry weight [5,12].
Figure 1. Relationship of extracellular water/total body water ratio
(edema level) and human atrial natriuretic peptide in post-hemodialysis
patients.
Figure 2. Relationship of extracellular water/total body water ratio
(edema level) and albumin in post-hemodialysis patients
M. Okamoto, M. Fukui, A. Kurusu, et al
210 Kaohsiung J Med Sci May 2006 • Vol 22 • No 5
In summary, the levels of hANP in the edematous group
(ECW/TBW * 0.35) were significantly higher than those in
the nonedematous group (ECW/TBW < 0.34) in HD patients.
It appears that BIA is a useful method to evaluate the dry
weight in HD patients.
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